Exerkines in health, resilience and disease

The workshop that set the foundation for this Review article was supported by the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH). The listed authors acknowledge the support of the following grants. L.S.C.: NIH grant R01DK098203; B.H.G.: NIH grant U01AR071133; A.L.: Spanish Ministry of Economy and Competitiveness and Fondos FEDER (PI18/00139); C.M.: European Federation of the Study of Diabetes/MSD, Occitanie Region/FEDER funds (DIABKINES, MP0021755 and Enterosys); B.K.P.: TrygFonden for the Centre for PA Research (CFAS); A.P.: Texas Health Resources Clinical Scholarship, Gilead Sciences Research Scholar Program, NIH National Institute of Aging GEMSSTAR grant (1R03AG067960-01), and Applied Therapeutics; J.M.R.: NIH grant HL150327-01A1; H.v.P.: NIH National Institute on Aging (NIA)/NIH IRP and the FDOH Ed and Ethel Moore Alzheimer’s Disease Research program; K.I.S.: NIH grants R01-HL138738 and R01-AG060542; A.E.T.: National Institute for Health Research (NIHR) Leicester Biomedical Research Centre; J.M.T.: NIH grant 1R01HL142879; S.T.: NIH grants U01AR071133; J.R.Z.: Swedish Research Council for Sport Science (P2018-0097), Swedish Research Council (Vetenskapsrådet) (2015-00165), and Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen (NNF18CC0034900); M.P.S.: NIH grants U24DK112348 and U54DK102556.